Schedule Update - effective 1 May 2010 (text extract)

This is the text extract for Schedule Update - effective 1 May 2010, browse documents here.

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 May 2010 Section H for April and May 2010

Contents

Summary of PHARMAC decisions effective 1 May 2010 ................................ 3 Gemcitabine hydrochloride and vinorelbine – access widening ..................... 5 Lignocaine urethral syringe – new listing ...................................................... 5 Blood Glucose Test Strip – claiming reminder ................................................ 5 Sumatriptan – Arrow-Sumatriptan tablets smaller pack size continued availability .................................................................................................. 6 Diclofenac sodium – delisting of alternative brands ...................................... 6 Moclobemide – delisting of GenRx Moclobemide brand ............................... 6 Tri-phasic oral contraceptives – delisting ....................................................... 7 Testosterone undecanoate capsules .............................................................. 7 Minerals – amendment to presentation descriptions .................................... 7 Laxofest – presentation amendment ............................................................. 7 Tender News .................................................................................................. 8 Looking Forward ........................................................................................... 8 Sole Subsidised Supply products cumulative to May 2010 ............................ 9 New Listings ................................................................................................ 18 Changes to Restrictions ............................................................................... 19 Changes to Subsidy and Manufacturer’s Price............................................. 22 Changes to Sole Subsidised Supply ............................................................. 23 Delisted Items ............................................................................................. 24 Items to be Delisted .................................................................................... 25 Section H changes to Part II ........................................................................ 27 Section H changes to Part IV ....................................................................... 29 Index ........................................................................................................... 30

Summary of PharmaC decisions

effeCtive 1 maY 2010 New listings (page 18) • Bendrofluazide (Arrow-Bendrofluazide) tab 2.5 mg – up to 150 tab available on a PSO • Bendrofluazide (Arrow-Bendrofluazide) tab 5 mg • Testosterone undecanoate (Arrow-Testosterone) cap 40 mg – Retail pharmacySpecialist • Lignocaine (Pfizer) gel 2%, 10 ml urethral syringe • Fluorouracil sodium (Fluorouracil Ebewe) inj 50 mg per ml, 10 ml, 5 inj pack – PCT only – Specialist Changes to restrictions (pages 19-21) • Docusate sodium cap 50 mg (Laxofast 50) and cap 120 mg (Laxofast 120) – amended presentation • Calcium carbonate (Calsource) tab eff 1.75 g (1 g elemental) – chemical and presentation description amended, and addition of elemental strength • Calcium carbonate tab 1.25 g (500 mg elemental) (Calci-Tab 500) and tab 1.5 g (600 mg elemental) (Calci-Tab 600) – addition of elemental strength • Sodium fluoride (PSM) tab 1.1 mg (0.5 mg elemental) – addition of elemental strength • Ferrous fumarate (Ferro-tab) tab 200 mg (65 mg elemental) – addition of elemental strength • Ferrous fumarate with folic acid (Ferro-F-Tabs) tab 310 mg (100 mg elemental) with folic acid 350 µg – addition of elemental strength • Ferrous gluconate with ascorbic acid (Healtheries Iron with Vitamin C) tab 170 mg (20 mg elemental) with ascorbic acid 40 mg – addition of elemental strength • Ferrous sulphate (Ferro-Gradumet) tab long-acting 325 mg (105 mg elemental) and (Ferodan) oral liq 150 mg per 5 ml (30 mg elemental per 1 ml) – addition of elemental strength • Ferrous sulphate with folic acid (Ferrograd-Folic) tab long-acting 325 mg (105 elemental) with folic acid 350 µg – addition of elemental strength • Magnesium sulphate (Mayne) inj 49.3%, 5 ml – amended presentation • Zinc sulphate (Zincaps) cap 137.4 mg (50 mg elemental) – addition of elemental strength • Gemcitabine hydrochloride (Gemcitabine Ebewe and Gemzar) inj 200 mg and 1 g, and (Baxter) inj 1 mg for ECP – amended Special Authority criteria • Vinorelbine (Navelbine and Vinorelbine Ebewe) inj 10 mg per ml, 1 ml and 5 ml, and (Baxter) inj 1 mg for ECP – amended Special Authority criteria

Summary of PharmaC decisions – effective 1 may 2010 (continued) Decreased subsidy (page 22) • Crotamition (Eurax) crm 10% • Chlorhexidine gluconate (Orion) handrub 1% with ethanol 70% • Pregnancy tests – hCG urine (MDS Quick Card) cassette, 25 test OP • Lamivudine (3TC) tab 150 mg and oral liq 10 mg per ml • Cisplatin (Cisplatin Ebewe) inj 1 mg per ml, 50 ml and 100 ml • Megestrol acetate (Megace) tab 160 mg

Pharmaceutical Schedule - Update News

Gemcitabine hydrochloride and vinorelbine – access widening

From 1 May 2010; the Special Authority criteria for subsidy of all listed presentations of gemcitabine hydrochloride and vinorelbine will be widened to include Hodgkin’s Disease and T-cell Lymphoma – see page 19 for more details. Gemcitabine hydrochloride and vinorelbine are Pharmaceutical Cancer Treatments.

Lignocaine urethral syringe – new listing

A new presentation of lignocaine gel 2% urethral syringe (Pfizer) will be listed in the Pharmaceutical Schedule from 1 May 2010. This provides an alternative lignocaine-containing urethral syringe to the currently listed product (lignocaine gel 2% with chlorhexidine 0.05%), which will also remain fully funded.

Blood Glucose Test Strip – claiming reminder

It has been bought to PHARMAC’s attention that some pharmacies may be mistakenly claiming for 50 packs of CareSens and/or On Call Advanced blood glucose test strips and lancets instead of claiming for 1 OP. PHARMAC would like to remind pharmacy staff to take care when dispensing these products as a quantity of 1 entered into dispensing software will result in one pack (50 strips and 5 lancets) being claimed.

6 Pharmaceutical Schedule - Update News

Sumatriptan – Arrow-Sumatriptan smaller pack size continued availability

Arrow-Sumatriptan tab 50 mg (4 tablet pack) and 100 mg (2 tablet pack) will remain fully subsidised and will not be delisted from 1 May 2010 as previously notified. The smaller pack sizes will continue to be listed in the Pharmaceutical Schedule at their current prices and subsidies until stock is exhausted, when PHARMAC will provide six months notice before delisting them from the Pharmaceutical Schedule.

Diclofenac sodium – delisting of alternative brands

The Apo-Diclo SR brand of diclofenac sodium long-acting 75 mg and long-acting 100 mg tablets will be delisted from the Pharmaceutical Schedule from 1 November 2010 as supplies of this brand are now exhausted. The Diclax SR brand of both strengths in the 500-tablet pack size will remain fully subsidised; however, the 30-tablet pack size of Diclax SR 75 mg tablets will be delisted from 1 August 2010. As notified in the April 2010 Update to the Pharmaceutical Schedule, the Voltaren SR brand of diclofenac sodium 75 mg longacting tablets will be delisted from 1 June 2010.

Moclobemide – delisting of GenRx Moclobemide brand

Supply of the Apo-Moclobemide brand of moclobemide tablets 150 mg and 300 mg has recently been resumed. As a result, the GenRx Moclobemide brand will be delisted from the Pharmaceutical Schedule from 1 November 2010. Sole Supply Status for ApoMoclobemide will be reinstated from 1 November 2010.

Pharmaceutical Schedule - Update News

Tri-phasic oral contraceptives – delisting

PHARMAC has received notice that the last remaining supplier of subsidised tri-phasic oral contraceptives intends to discontinue from the New Zealand market. Trifeme will be delisted from 1 November 2010 (six months after notification from the supplier of stock depletion). The Hormone and Contraceptive Subcommittee of PTAC considered that there was no clinical need for a tri-phasic oral contraceptive to be subsidised and that Brevinor 1 would be an appropriate alternative.

Testosterone undecanoate capsules

On 24 December 2009 PHARMAC notified that Arrow Pharmaceuticals brand of testosterone undecanoate – ArrowTestosterone - had been awarded the 2008/09 Tender. The listing for this product was delayed by 3 months, until 1 May 2010. This will result in all the timelines for the tender process being moved by the same period of time. The listing of ArrowTestosterone will occur on 1 May 2010, reference pricing of non-tender winning brands, Andriol Testocaps and Panteston, will occur on 1 July 2010 and Sole Subsidised Supply for Arrow-Testosterone will commence on 1 October 2010.

Minerals – amendment to presentation descriptions

Following suggestions from healthcare professionals and a review by PHARMAC staff the line item descriptions of mineral products in the Pharmaceutical Schedule have been amended. The line item descriptions now specify the content of elemental content in brackets as well as the total weight of the salt form. This is expected to aid prescribers and pharmacists when determining dosage of minerals to prescribe/dispense. Full details of the changes can be found on page 19.

Laxofast – presentation amendment

The presentation of the Laxofast brand of docusate sodium (Laxofast 50 and Laxofast 120) has been amended from tablets to capsules. The presentation was listed as tablets last month when they are in fact capsules. PHARMAC would like to apologise for any confusion this may have caused.

tender News

Sole Subsidised Supply changes – effective 1 June 2010

Chemical Name Flucloxacillin sodium Flucloxacillin sodium Paracetamol with codeine Pindolol Pindolol Pindolol Presentation; Pack size Cap 250 mg; 250 cap Cap 500 mg; 500 cap Tab paracetamol 500 mg with codeine phosphate 8 mg; 100 tab Tab 5 mg; 100 tab Tab 10 mg; 100 tab Tab 15 mg; 100 tab Sole Subsidised Supply brand (and supplier) AFT (AFT) AFT (AFT) ParaCode (Arrow) Apo-Pindolol (Apotex) Apo-Pindolol (Apotex) Apo-Pindolol (Apotex)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Decision for implementation 1 June 2010 • Risperidone (Ridal) tab 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg – subsidy decrease Decision for implementation 1 July 2010 • Metoprolol succinate (AFT-Metoprolol CR and Betaloc CR) tab long-acting 23.75 mg, 47.5 mg, 95 mg and 190 mg – subsidy decrease

Sole Subsidised Supply Products – cumulative to May 2010

Generic Name

Acarbose Acetazolamide Allopurinol Alprazolam Amantadine hydrochloride Amlodipine Amoxycillin

Presentation

Tab 50 mg & 100 mg Tab 250 mg Tab 100 mg & 300 mg Tab 250 µg, 500 µg & 1 mg Cap 100 mg Tab 5 mg & 10 mg Grans for oral liq 250 mg per 5 ml Drops 125 mg per 1.25 ml Inj 250 mg, 500 mg & 1 g Cap 250 mg & 500 mg

Brand Name Expiry Date*

Glucobay Diamox Apo-Allopurinol Arrow-Alprazolam Symmetrel Apo-Amlodipine Ospamox Ospamox Paediatric Drops Ibiamox Apo-Amoxi Curam Curam Synermox AFT Ethics Aspirin Ethics Aspirin EC Pacific Atenolol AstraZeneca Arrow-Azithromycin Pacifen Sandoz Beta Scalp Fibalip Bicalox Lax-Tabs AFT Marcain Isobaric Marcain Heavy healthE API Miacalcic Airflow Calsource 2011 2011 2010 2012 2012 2012 2012 2011 2012 2011 2011 2010 2011 2010 2012 2011 2012 2011 2012 2011 2011 2010 2011 2011 2012 2011 2010 2012

Amoxycillin clavulanate

Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml Tab amoxycillin 500 mg with potassium clavulanate 125 mg Crm 500 g Tab dispersible 300 mg Tab 100 mg Tab 50 mg & 100 mg Inj 600 µg, 1 ml Tab 500 mg Tab 10 mg Inj 1 mega u Scalp app 0.1% Tab 200 mg Tab 50 mg Tab 5 mg Eye drops 0.2% Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Crm, aqueous, BP Lotn, BP Inj 100 iu per ml, 1 ml Cap 0.25 µg & 0.5 µg Tab eff 1 g

Aqueous cream Aspirin Atenolol Atropine sulphate Azithromycin Baclofen Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Bezafibrate Bicalutamide Bisacodyl Brimonidine tartrate Bupivicaine hydrochloride Calamine Calcitonin Calcitriol Calcium

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

Sole Subsidised Supply Products – cumulative to May 2010

Generic Name

Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Cefuroxime sodium Cephalexin monohydrate Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate Ciclopiroxolamine Ciprofloxacin Citalopram Clarithromycin Clobetasol propionate

Presentation

Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml Inj 500 mg & 1 g Inj 750 mg & 1.5 g Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Crm BP Tab 10 mg Oral liq 1 mg per ml Eye oint 1% Soln 4% Nail soln 8% Tab 250 mg, 500 mg & 750 mg Tab 20 mg Tab 250 mg Grans for oral liq 125 mg per 5 ml Crm 0.05% Oint 0.05% Scalp app 0.05% Tab 500 µg & 2 mg TDDS 2.5 mg, 100 µg per day TDDS 5 mg, 200 µg per day TDDS 7.5 mg, 300 µg per day Inj 150 µg per ml, 1 ml Tab 25 µg Tab 150 µg Crm 1% Vaginal crm 1% with applicator(s) Vaginal crm 2% with applicators(s) Tab 15 mg, 30 mg & 60 mg Tab 500 µg Sach 5 g Inj 150 mg Powder for soln for oral use Tab 50 mg Tab 50 mg

Brand Name Expiry Date*

Calcium Folinate Ebewe Apo-Captopril Ranbaxy-Cefaclor Ranbaxy-Cefaclor Hospira Zinacef Cefalexin Sandoz Cefalexin Sandoz PSM Zetop Cetirizine-AFT Chlorsig Orion Batrafen Rex Medical Arrow-Citalopram Klamycin Klacid Dermol Dermol Dermol Paxam Catapres-TTS-1 Catapres-TTS-2 Catapres-TTS-3 Catapres Dixarit Catapres Clomazol Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Nausicalm Cycloblastin 2011 2010 2010 2011 2011 2012 2010 2011 2012 2011 2012 2011 2011 2010 2012

Clonazepam Clonidine

2011 2012

Clonidine hydrochloride

2012

Clotrimazole

2011 2010 2010 2010 2010 2010 2010 2012 2010

Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Cyclizine hydrochloride Cyclophosphamide

Sole Subsidised Supply Products – cumulative to May 2010

Generic Name

Cyproterone acetate Cyproterone acetate with ethinyloestradiol Desferrioxamine mesylate Desmopressin Dexamphetamine sulphate Dextrose Dextrose with electrolytes

Presentation

Tab 50 mg & 100 mg Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs Inj 500 mg Nasal spray 10 µg per dose Tab 5 mg Inj 50%, 10 ml Oral soln with electrolytes

Brand Name Expiry Date*

Siterone Ginet 84 Mayne Desmopressin-PH&T PSM Biomed Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit Diclohexal Voltaren Ophtha Voltaren Voltaren Dilzem Cardizem CD Pytazen SR Apo-Doxazosin AFT Clexane Comtan E-Mycin E-Mycin E-Mycin NZ Medical and Scientific Brevinor 21 Brevinor 1/21 Brevinor 1/28 Arrow-Etidronate Felo 5 ER Felo 10 ER Ferodan Fintral 2012 2012 2010 2011 2012 2011 2010 2011 2010 2011 2010

Diclofenac sodium

Tab EC 25 mg & 50 mg Eye drops 1 mg per ml Inj 25 mg per ml, 3 ml Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Tab 30 mg & 60 mg Cap long-acting 120 mg, 180 mg & 240 mg Tab long-acting 150 mg Tab 2 mg & 4 mg Oint BP Inj 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg & 150 mg Tab 200 mg Tab 400 mg Grans for oral liq 200 mg per 5 ml Grans for oral liq 400 mg per 5 ml Tab 10 µg Tab 35 µg with norethisterone 500 µg Tab 35 µg with norethisterone 1 mg Tab 35 µg with norethisterone 1 mg and 7 inert tab Tab 200 mg Tab long-acting 5 mg Tab long-acting 10 mg Oral liq 150 mg per 5 ml Tab 5 mg

2012 2011

Diltiazem hydrochloride

2011

Dipyridamole Doxazosin mesylate Emulsifying ointment Enoxaparin sodium (low molecular weight heparin) Entacapone Erythromycin ethyl succinate

2011 2010 2011 2012 2012 2012 2011 2012 2010

Ethinyloestradiol Ethinyloestradiol with norethisterone

Etidronate disodium Felodipine Ferrous sulphate Finasteride

Sole Subsidised Supply Products – cumulative to May 2010

Generic Name

Flucloxacillin sodium

Presentation

Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Inj 250 mg, 500 mg & 1 g Cap 50 mg, 150 mg & 200 mg Inj 50 mg Tab 10 mg Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored Metered aqueous nasal spray, 50 µg per dose Tab 40 mg Crm 2% Oint 2% Cap 100 mg, 300 mg & 400 mg Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Tab 600 µg Oral pump spray 400 µg per dose TDDS 5 mg & 10 mg

Brand Name Expiry Date*

AFT AFT Flucloxin Pacific Fludara Fludara Oral Ultraproct Ultraproct 2012 2011 2011 2011 2010

Fluconazole Fludarabine phosphate Fluocortolone caproate with fluocortolone pivalate and cinchocaine

Fluoromethalone Fluoxetine hydrochloride Fluticasone propionate Furosemide Fusidic acid Gabapentin Gentamicin sulphate Gliclazide Glipizide Glyceryl trinitrate

FML Fluox Fluox Flixonase Hayfever & Allergy Diurin 40 Foban Foban Nupentin Pfizer Apo-Gliclazide Minidiab Lycinate Nitrolingual Pumpspray Nitroderm TTS Serenace Serenace Douglas ABM PSM Colifoam Locoid DP Lotn HC Plaquenil Methopt Buscopan Gastrosoothe

2012 2010 31/1/13 2012 2010 31/7/12 2012 2011 2011 2011

Haloperidol Hydrocortisone

Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Tab 5 mg & 20 mg Powder Crm 1% Rectal foam 10%, CFC-free (14 applications) Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Tab 200 mg Eye drops 0.5% Inj 20 mg, 1 ml Tab 20 mg

2010 2012 2011 2012 2010 2011 2012 2011 2011

Hydrocortisone acetate Hydrocortisone butyrate Hydrocortisone with wool fat and mineral oil Hydroxychloroquine sulphate Hypromellose Hysocine N-butylbromide

Sole Subsidised Supply Products – cumulative to May 2010

Generic Name

Ibuprofen Ipratropium bromide

Presentation

Tab 200 mg Oral liq 100 mg per 5 ml Aqueous nasal spray, 0.03% Nebuliser soln, 250 µg per ml, 1 ml Nebuliser soln, 250 µg per ml, 2 ml Inj 50 mg per ml, 2 ml Cap 10 mg & 20 mg Cap 100 mg Shampoo 2% Oral liq 10 g per 15 ml Eye drops 50 µg per ml Eye drops 0.25% & 0.5% Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

Ethics Ibuprofen Fenpaed Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Ferrum H Oratane Sporanox Sebizole Duphalac Hysite Betagan Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril Nodia Loraclear Hayfever Relief Lorapaed Derbac M A-Lices Foremount Child’s Silicone Mask De-Worm Colofac Provera Pentasa Apotex Biodone Biodone Forte Biodone Extra Forte Methatabs Methoblastin Methotrexate Ebewe Methotrexate Ebewe 2012 2010 2010 2012 2010 2010

Iron polymaltose Isotretinoin Itraconazole Ketoconazole Lactulose Latanoprost Levobunolol Lignocaine hydrochloride

2011 2012 2010 2011 2010 2012 2010 2010

Lignocaine with prilocaine

2010

Lisinopril Loperamide hydrochloride Loratadine

Malathion Mask for Spacer Device Mebendazole Mebeverine hydrochloride Medroxyprogesterone acetate Mesalazine Metformin hydrochloride Methadone hydrochloride

Liq 0.5% Shampoo 1% Device Tab 100 mg Tab 135 mg Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Tab immediate-release 500 mg & 850 mg Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab 5 mg Tab 2.5 mg & 10 mg Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml

2010 2011 30/9/11 2011 2011 2010 2012 2012 2012 2010 2012 2011

Methotrexate

Sole Subsidised Supply Products – cumulative to May 2010

Generic Name

Methyldopa Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate

Presentation

Tab 125 mg, 250 mg & 500 mg Tab 4 mg & 100 mg Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 2 ml Inj 500 mg Inj 1 g Inj 5 mg per ml, 2 ml Crm 2% Crm 0.1% Oint 0.1% Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab immediate release 10 mg & 20 mg Inj 10 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Tab 40 mg & 80 mg Tab 50 mg Tab 250 mg Tab 500 mg Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 200 mg

Brand Name Expiry Date*

Prodopa Medrol Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Multichem m-Mometasone m-Mometasone RA-Morph RA-Morph RA-Morph RA-Morph Sevredol Mayne Mayne Apo-Nadolol ReVia Noflam 250 Noflam 500 Sonaflam AstraZeneca Viramune Suspension Viramune Habitrol Habitrol Habitrol Habitrol Noriday 28 Primolut N Norpress Nilstat Nilstat Nilstat 2011 2012 2011 2011 2012

Metoclopramide hydrochloride Miconazole nitrate Mometasone furoate Morphine hydrochloride

2011 2011 2012 2012

Morphine sulphate

2012 2011 2010 2010 2012 2010 2010 2012

Nadolol Naltrexone hydrochloride Naproxen Naproxen sodium Neostigmine Nevirapine

Nicotine

Patch 7 mg, 14 mg & 21 mg Lozenge 1 mg & 2 mg Gum 2 mg & 4 mg (Fruit) Gum 2 mg & 4 mg (Mint) Tab 350 µg Tab 5 mg Tab 10 mg & 25 mg Oral liq 100,000 u per ml, 24 ml OP Cap 500,000 u Tab 500,000 u

2010

Norethisterone Nortriptyline hydrochloride Nystatin

2012 2011 2011 2011 2010

Sole Subsidised Supply Products – cumulative to May 2010

Generic Name

Omeprazole

Presentation

Cap 10 mg, 20 mg & 40 mg Inj 40 mg

Brand Name Expiry Date*

Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Zofran Zofran Zydis Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol Pantocid IV Dr Reddy’s Pantoprazole Pharmacare Paracare Junior Paracare Double Strength Lacri-Lube Loxamine Breath-Alert Pegasys Pegasys Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack Permax A-Scabies AFT AFT Cilicaine VK Prefrin Pizaccord 2011

Ondansetron Oxybutynin Oxycodone hydrochloride Oxytocin

Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml & 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml Inj 40 mg Tab 20 mg & 40 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Eye oint with soft white paraffin Tab 20 mg Low range and Normal range Inj 135 µg prefilled syringe Inj 180 µg prefilled syringe Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112 Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168 Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112 Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168 Tab 0.25 mg & 1 mg Lotn 5% Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg & 500 mg Eye drops 0.12% Tab 15 mg, 30 mg & 45 mg

2010 2010 2010 2012

Pamidronate disodium

2011

Pantoprazole

2010

Paracetamol

2011

Paraffin liquid with soft white paraffin Paroxetine hydrochloride Peak Flow Meter Pegylated interferon alpha-2A

2010 2010 30/9/11 31/12/12

Pergolide Permethrin Phenoxymethylpenicillin (Penicillin V) Phenylephrine hydrochloride Pioglitazone

2011 2011 2010

2010 2012

Sole Subsidised Supply Products – cumulative to May 2010

Generic Name

Pizotifen Poloxamer Polyvinyl alcohol Potassium chloride Prazosin hydrochloride Prednisone Prednisone sodium phosphate Procaine penicillin Promethazine Quinapril Quinapril with hydroclorothiazide

Presentation

Tab 500 µg Oral drops 10% Eye drops 1.4% Eye drops 3% Tab long-acting 600 mg Tab 1 mg, 2 mg & 5 mg Tab 1 mg, 2.5 mg, 5 mg & 20 mg Oral liq 5 mg per ml Inj 1.5 mega u Tab 10 mg & 25 mg Tab 5 mg, 10 mg & 20 mg Tab 10 mg with hydroclorothiazide 12.5 mg Tab 20 mg with hydroclorothiazide 12.5 mg Tab 300 mg Oral liq 150 mg per 10 ml Cap 150 mg Tab 0.25 mg, 1 mg, 2 mg and 5 mg Tab 150 mg & 300 mg Nebuliser soln, 1 mg per ml, 2.5 ml Nebuliser soln, 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratopium bromide 0.5 mg per vial, 2.5 ml Tab 5 mg Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg Grans eff 4 g sachets Nasal spray, 4% Tab 80 mg & 160 mg 230 ml Tab 50 mg & 100 mg Liq Soln 2.3%

Brand Name Expiry Date*

Sandomigran Coloxyl Vistil Vistil Forte Span-K Apo-Prazo Apo-Prednisone Redipred Cilicaine Allersoothe Accupril Accuretic 10 Accuretic 20 Q 300 Peptisoothe Mycobutin Ropin ArrowRoxithromycin Asthalin Asthalin Salapin Duolin 2012 2010 2010 2010 2012 2012 2010 2012 2012 2011 2011 2012 2010 2011 2012 2011 2011 2011 2011

Quinine sulphate Ranitidine hydrochloride Rifabutin Ropinirole hydrochloride Roxithromycin Salbutamol

Salbutamol with ipratropium bromide Selegiline hydrochloride Simvastatin

Apo-Selegiline Arrow-Simva 10 mg Arrow-Simva 20 mg Arrow-Simva 40 mg Arrow-Simva 80 mg Ural Rex Mylan Space Chamber Arrow-Sumatriptan Midwest Pinetarsol

2012 2011

Sodium citro-tartrate Sodium cromoglycate Sotalol Spacer Device Sumatriptan Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein

2010 2012 2012 30/9/11 2013 2010 2011

Sole Subsidised Supply Products – cumulative to May 2010

Generic Name

Temazepam Terazosin hydrochloride Terbinafine Testosterone cypionate Tetracosactrin Timolol maleate Triamcinolone acetonide

Presentation

Tab 10 mg Tab 2 mg & 5 mg Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Inj 250 µg Inj 1 mg per ml, 1 ml Tab 10 mg Eye drops 0.25% & 0.5% Crm 0.02% Oint 0.02% Inj 40 mg per ml, 1 ml 0.1% in Dental Paste USP Tab 300 mg Cap 5 mg Cap 300 mg Inj 50 mg per ml, 10 ml Oint BP Cap 220 mg Tab 7.5 mg

Brand Name Expiry Date*

Normison Apo-Terazosin Apo-Terbinafine Depo-Testosterone Synacthen Synacthen Depot Apo-Timol Apo-Timop Aristocort Aristocort Kenacort-A40 Oracort TMP Navoban Actigall Pacific PSM Zincaps Apo-Zopiclone 2011 2010 2011 2011 2011 2012 2011 2011

Trimethoprim Tropisetron Ursodeoxycholic acid Vancomycin hydrochloride Zinc and castor oil Zinc sulphate Zopiclone May changes in bold

2011 2012 2011 2011 2011 2011 2011

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 May 2010

55 77 109 138 BENDROFLUAZIDE ❋ Tab 2.5 mg – Up to 150 tab available on a PSO ......................... 7.58 May be supplied on a PSO for reasons other than emergency. ❋ Tab 5 mg ............................................................................... 11.75 TESTOSTERONE UNDECANOATE – Retail pharmacy–Specialist Cap 40 mg .............................................................................. 79.92 LIGNOCAINE Gel 2%, 10 ml urethral syringe ................................................. 43.26 FLUOROURACIL SODIUM Inj 50 mg per ml, 10 ml – PCT only – Specialist ....................... 24.75 500 500 100 10 5 ✔ Arrow Bendrofluazide ✔ Arrow Bendrofluazide ✔ Arrow-Testosterone ✔ Pfizer ✔ Fluorouracil Ebewe

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 May 2010

34 38 38 38 38 38 38 39 39 DOCUSATE SODIUM – Only on a prescription ❋ Tab Cap 50 mg ......................................................................... 3.95 ❋ Tab Cap 120 mg ....................................................................... 5.49 CALCIUM CARBONATE ❋ Tab eff 1.75 g (1 g elemental) .................................................. 6.54 CALCIUM CARBONATE ❋ Tab 1.25 g (500 mg elemental) ................................................ 9.18 ❋ Tab 1.5 g (600 mg elemental) ................................................ 10.33 SODIUM FLUORIDE Tab 1.1 mg (0.5 mg elemental) ................................................ 4.00 FERROUS FUMARATE Tab 200 mg (65 mg elemental) ................................................ 4.35 FERROUS FUMARATE WITH FOLIC ACID Tab 310 mg (100 mg elemental) with folic acid 350 µg ............ 4.75 FERROUS GLUCONATE WITH ASCORBIC ACID ❋ Tab 170 mg (20 mg elemental) with ascorbic acid 40 mg ....... 12.04 FERROUS SULPHATE ❋ Tab long-acting 325 mg (105 mg elemental) ............................ 5.06 (15.58) ❋‡ Oral liq 150 mg per 5 ml (30 mg elemental per 1 ml) ........... 10.30 FERROUS SULPHATE WITH FOLIC ACID ❋ Tab long-acting 325 mg (105 mg elemental) with folic acid 350 µg .................................................................. 1.80 (3.73) MAGNESIUM SULPHATE Inj 49.3%, 5 ml ....................................................................... 26.60 ZINC SULPHATE ❋ Cap 220 137.4 mg (50 mg elemental) ................................... 10.00 100 100 30 250 250 100 100 60 500 150 500 ml Ferro-Gradumet ✔ Ferodan ✔ Laxofast 50 ✔ Laxofast 120 ✔ Calsource ✔ Calci-Tab 500 ✔ Calci-Tab 600 ✔ PSM ✔ Ferro-tab ✔ Ferro-F-Tabs ✔ Healtheries Iron with Vitamin C

30 Ferrograd-Folic 10 100 ✔ Mayne ✔ Zincaps

39 39 138

GEMCITABINE HYDROCHLORIDE – PCT only – Specialist – Special Authority see SA1012 0877 Inj 1 g ................................................................................... 245.00 1 ✔ Gemcitabine Ebewe 349.20 ✔ Gemzar Inj 200 mg .............................................................................. 49.00 1 ✔ Gemcitabine Ebewe 78.00 ✔ Gemzar Inj 1 mg for ECP ....................................................................... 0.26 1 mg ✔ Baxter ➽ SA1012 0877 Special Authority for Subsidy Initial application - (Hodgkin’s disease) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: continued...

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 May 2010 (continued)

continued... All of the following 1 The patient has Hodgkin’s disease*; and 2 Either 2.1 Disease has failed to respond to second-line salvage chemotherapy treatment; or 2.2 Disease has relapsed following transplant; or 2.3 The patient is unsuitable for, or intolerant to, second-line salvage chemotherapy or high dose chemotherapy and transplant. 3 Gemcitabine to be given for a maximum of 6 treatment cycles. Initial application - (T-cell Lymphoma) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: All of the following 1 The patient has T-cell lymphoma*; and 2 Gemcitabine to be given for a maximum of 6 treatment cycles. Initial application - (Other indications) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: Any of the following: 1 The patient has non small cell lung carcinoma (stage IIIa, or above); or 2 The patient has advanced malignant mesothelioma*; or 3 The patient has advanced pancreatic carcinoma; or 4 The patient has ovarian, fallopian tube* or primary peritoneal carcinoma*; or 5 The patient has advanced transitional cell carcinoma of the urothelial tract (locally advanced or metastatic). Renewal - (Other Indications) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: Either: 1 The patient requires continued therapy; or 2 The tumour has relapsed and requires re-treatment. Note: Indications marked with a * are Unapproved Indications.

143

VINORELBINE – PCT only – Specialist – Special Authority see SA1013 0901 Inj 10 mg per ml, 1 ml ............................................................ 24.00 1 42.00 Inj 10 mg per ml, 5 ml ........................................................... 120.00 1 210.00 Inj 1 mg for ECP ........................................................................ 2.71 1 mg

✔ Navelbine ✔ Vinorelbine Ebewe ✔ Navelbine ✔ Vinorelbine Ebewe ✔ Baxter

➽ SA1013 0901 Special Authority for Subsidy Initial application - (Hodgkin’s disease) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: All of the following 1 The patient has Hodgkin’s disease*; and 2 Either 2.1 Disease has failed to respond to second-line salvage chemotherapy treatment; or 2.2 Disease has relapsed following transplant; or 2.3 The patient is unsuitable for, or intolerant to, second-line salvage chemotherapy or high dose chemotherapy and transplant. 3 Vinorelbine to be given for a maximum of 6 treatment cycles. Initial application - (T-cell Lymphoma) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: continued... Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 May 2010 (continued)

continued... All of the following 1 The patient has T-cell lymphoma*; and 2 Vinorelbine to be given for a maximum of 6 treatment cycles.

Initial application – (Other indications) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: Any of the following: 1 The patient has metastatic breast cancer; or 2 The patient has non-small cell lung cancer (stage IIIa, or above); or 3 All of the following: 3.1 The patient has stage IB-IIIA non-small cell lung cancer; and 3.2 Vinorelbine is to be given as adjuvant treatment in combination with cisplatin; and 3.3 The patient has good performance status (WHO/ECOG grade 0-1). Renewal – (Other Indications) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: Either: 1 The patient requires continued therapy; or 2 The tumour has relapsed and requires re-treatment. Note: Indications marked with a * are Unapproved Indications.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 May 2010

61 CROTAMITON ( subsidy) a) Only on a prescription b) Not in combination Crm 10% .................................................................................. 3.79 (4.45)

20 g OP Eurax

CHLORHEXIDINE GLUCONATE – Subsidy by endorsement ( subsidy) a) No more than 500 ml per month b) Only if prescribed for a dialysis patient and the prescription is endorsed accordingly. ❋ Handrub 1% with ethanol 70% .................................................. 4.60 500 ml (5.40) PREGNANCY TESTS - HCG URINE ( subsidy) a) Up to 200 test available on a PSO b) Only on a PSO Cassette ................................................................................. 14.25 (19.00)

Orion

25 test OP MDS Quick Card

LAMIVUDINE – Special Authority see SA0779 – Hospital pharmacy [HP1] ( subsidy) Tab 150 mg ......................................................................... 153.60 60 ✔ 3TC Oral liq 10 mg per ml .............................................................. 50.00 240 ml OP ✔ 3TC CISPLATIN – PCT only – Specialist ( subsidy) Inj 1 mg per ml, 50 ml ............................................................ 15.00 Inj 1 mg per ml, 100 ml .......................................................... 21.00 MEGESTROL ACETATE – Retail pharmacy-Specialist ( subsidy) Tab 160 mg ........................................................................... 57.92 (74.25) 1 1 30 Megace ✔ Cisplatin Ebewe ✔ Cisplatin Ebewe

136

146

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Sole Subsidised Supply

Effective 1 May 2010

For the list of new Sole Subsidised Supply products effective 1 May 2010 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 9-17.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 May 2010

30 37 65 METFORMIN HYDROCHLORIDE ❋ Tab immediate-release 500 mg ................................................. 8.09 ❋ Tab immediate-release 850 mg ................................................. 6.67 CALCITRIOL ❋ Cap 0.25 µg ........................................................................... 10.10 ❋ Cap 0.5 µg ............................................................................. 18.73 PERMETHRIN Crm 5% .................................................................................... 3.65 (4.20) WOOL FAT WITH MINERAL OIL – Only on a prescription ❋ Lotn hydrous 3% with mineral oil .............................................. 1.12 (5.00) 2.10 (9.38) 500 250 100 100 30 g OP Lyderm 200 ml OP Alpha-Keri Lotion 375 ml OP Alpha-Keri Lotion ✔ Arrow-Metformin ✔ Arrow-Metformin ✔ Calcitriol-AFT ✔ Calcitriol-AFT

SUNSCREENS, PROPRIETARY – Subsidy by endorsement Only if prescribed for a patient with severe photosensitivity secondary to a defined clinical condition and the prescription is endorsed accordingly. Lotn ......................................................................................... 3.19 125 ml OP (8.82) Aquasun Sensitive SPF 30+ AMOXYCILLIN Grans for oral liq 250 mg per 5 ml – Up to 200 ml available on a PSO ............................................................................... 1.27 LAMOTRIGINE ▲ Tab dispersible 200 mg ........................................................ 101.80 SUMATRIPTAN Tab 50 mg ............................................................................... 1.55 (12.00) (22.00) Tab 100 mg ............................................................................. 1.55 (12.00) (22.00) TENIPOSIDE – PCT only – Specialist Inj 10 mg per ml, 5 ml .......................................................... 845.11 Inj 50 mg for ECP ................................................................... 84.51 DEXTROCHLORPHENIRAMINE MALEATE ❋ Tab 2 mg ................................................................................. 1.26 (5.60) 2.52 (9.99)

100 ml 56 4

✔ Ranbaxy Amoxicillin ✔ Arrow-Lamotrigine

117 119

Sumagran Imigran 2 Sumagran Imigran 10 ✔ Vumon 50 mg OP ✔ Baxter 25 Polaramine 50 Polaramine

143

151

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 August 2010

61 CROTAMITON a) Only on a prescription b) Not in combination Crm 10% .................................................................................. 3.79 (4.45)

20 g OP Eurax

CHLORHEXIDINE GLUCONATE – Subsidy by endorsement a) No more than 500 ml per month b) Only if prescribed for a dialysis patient and the prescription is endorsed accordingly. ❋ Handrub 1% with ethanol 70% .................................................. 4.60 500 ml (5.40) PREGNANCY TESTS - HCG URINE a) Up to 200 test available on a PSO b) Only on a PSO Cassette ................................................................................. 14.25 (19.00) DICLOFENAC SODIUM ❋ Tab long-acting 75 mg ............................................................. 3.10 Note – Diclax SR tab long-acting 75 mg, 500 tab pack, remains listed. DEXTROPROPOXYPHENE WITH PARACETAMOL Tab napsylate 50 mg with paracetamol 325 mg ...................... 14.50 (22.50) Cap hydrochloride 32.5 mg with paracetamol 325 mg ............... 3.98 (4.90) 19.91 (33.14) MEGESTROL ACETATE – Retail pharmacy-Specialist Tab 160 mg ........................................................................... 57.92 (74.25)

Orion

25 test OP MDS Quick Card 30 ✔ Diclax SR

100 110

500 Paradex 100 Capadex 500 Capadex

146

30 Megace

Effective 1 November 2010

55 62 72 FUROSEMIDE ❋ Tab 500 mg ........................................................................... 12.00 HYDROCORTISONE ❋ Crm 1% – Only on a prescription .............................................. 2.44 ETHINYLOESTRADIOL WITH LEVONORGESTREL ❋ Tab ethinyloestradiol 30 µg with levonorgestrel 50 µg (6) and tab ethinyloestradiol 40 µg with levonorgestrel 75 µg (5), and tab ethinyloestradiol 30 µg with levonorgestrel 125 µg (10) and 7 inert tab – Up to 84 tab available on a PSO................ 6.62 Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. 100 100 g ✔ Diurin 500 ✔ Lemnis Fatty Cream HC

✔ Trifeme

▲

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 November 2010 (continued)

79 DYDROGESTERONE Tab 10 mg ............................................................................. 27.50 (29.90) Note – Duphaston tab 10 mg, 28 tab pack remains listed. DANAZOL – Retail pharmacy-Specialist Cap 200 mg ........................................................................... 29.35 DICLOFENAC SODIUM ❋ Tab long-acting 75 mg ........................................................... 22.78 ❋ Tab long-acting 100 mg ......................................................... 34.32 Note – Diclax SR tab long-acting 75 mg, 500 tab pack, remains listed. CLOMIPRAMINE HYDROCHLORIDE Tab 25 mg ............................................................................. 26.00 50 Duphaston

83 100 112 113

30 500 500

✔ D-Zol ✔ Apo-Diclo SR ✔ Apo-Diclo SR

500

✔ Clopress

MOCLOBEMIDE Note: There is a significant cost differential between moclobemide and fluoxetine (moclobemide being about three times more expensive). For depressive syndromes it is therefore more cost-effective to start treatment with fluoxetine first before considering prescribing moclobemide. Tab 150 mg ............................................................................. 8.31 60 ✔ GenRx Moclobemide Tab 300 mg ........................................................................... 18.80 60 ✔ GenRx Moclobemide FLUOROURACIL SODIUM Inj 50 mg per ml, 10 ml – PCT only – Specialist ......................... 4.95 1 ✔ Fluorouracil Ebewe Note – Fluorouracil Ebewe inj 50 mg per ml, 10 ml, 5 injection pack listed 1 May 2010.

138

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II

Effective 1 May 2010

BENDROFLUAZIDE Tab 2.5 mg.....................................Arrow7.58 Bendrofluazide Tab 5 mg........................................Arrow11.75 Bendrofluazide 500 500 1% 1% Jul-10 Jul-10 Neo-Naclex Neo-Naclex

CISPLATIN ( price and addition of HSS) Inj 1 mg per ml, 50 ml ....................Cisplatin Ebewe 15.00 1 1% Jul-10 Inj 1 mg per ml, 100 ml ..................Cisplatin Ebewe 21.00 1 1% Jul-10 Note – Mayne cisplatin inj 1 mg per ml, 50 ml and 100 mg, to be delisted 1 July 2010. CLINDAMYCIN (addition of HSS) Inj phosphate 150 mg per ml, 4 ml ..................Dalacin C

DBL Cisplatin DBL Cisplatin

16.00

1 500

Jul-10

(B)

CLOMIPRAMINE HYDROCHLORIDE Tab 25 mg......................................Clopress 26.00 Note – Clopress tab 25 mg to be delisted 1 July 2010. DANAZOL Cap 200 mg ...................................D-Zol 29.35 Note– D-Zol cap 200 mg to be delisted 1 November 2010. DOCUSATE SODIUM (correction of presentation) Cap tab 50 mg ...............................Laxofast 50 Cap tab 120 mg .............................Laxofast 120 3.95 5.49

100 100

1% 1%

Jun-10 Jun-10

Coloxyl Coloxyl Mayne

FLUOROURACIL SODIUM (addition of new pack size) Inj 50 mg per ml, 10 ml ..................Fluorouracil 24.75 5 1% Oct-07 Ebewe Note – Fluorouracil Ebewe inj 50 mg per ml, 10 ml, 1 injection pack, to be delisted 1 July 2010. FUROSEMIDE Tab 500 mg....................................Diurin 500 12.00 Note – Diurin 500 tab 500 mg to be delisted 1 July 2010. LIGNOCAINE Gel 2%, 10 ml urethral syringe .......Pfizer MEDROXYPROGESTERONE ACETATE (addition of HSS) Inj 150 mg per ml, 1 ml, syringe .....Depo-Provera 43.26 7.15 100

10 1 30 100 30 100 30 1% 1% 1% 1% 1% 1% Jul-10 Jul-10 Jul-10 Jul-10 Jul-10 Jul-10 (B) Cycrin Cycrin Cycrin (B) (B)

MEDROXYPROGESTERONE ACETATE (continuation of HSS) Tab 2.5 mg.....................................Provera 3.09 Tab 5 mg........................................Provera 13.06 Tab 10 mg......................................Provera 6.85 Tab 100 mg....................................Provera 96.50 Tab 200 mg....................................Provera 70.50

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes Part II - effective 1 May 2010 (continued)

MOCLOBEMIDE (reinstatement of HSS) Tab 150 mg....................................Apo69.23 500 1% Moclobemide Tab 300 mg....................................Apo31.33 100 1% Moclobemide Note – GenRx Moclobemide tab 150 mg and 300 mg to be delisted 1 May 2010. TENOXICAM Inj 20 mg........................................AFT TESTOSTERONE UNDECANOATE Cap 40 mg ....................................ArrowTestosterone 9.95 79.92 1 100 1% 1% May-10 May-10 GenRx Moclobemide GenRx Moclobemide

Jul-10 Jul-10

(B) Andriol Testocaps Panteston

Effective 1 April 2010

AMBRISENTAN Tab 5 mg........................................Volibris Tab 10 mg......................................Volibris BISACODYL Suppos 5 mg..................................Dulcolax Suppos 10 mg................................Dulcolax CHLORAMPHENICOL ( price) Eye drops 0.5% .............................Chlorsig CIPROFLOXACIN ( price and addition of HSS) Inj 2 mg per ml, 100 ml ..................Aspen Ciprofloxacin 4,585.00 4,585.00 3.00 3.00 2.40 41.00 30 30 6 6 10 ml 10 1% Jun-10 Ciproxin DBL DP-Cipro Topistin Ufexil

DANAZOL Cap 200 mg ...................................Azol DIHYDROCODEINE TARTRATE Tab long-acting 60 mg....................DHC Continus DOCUSATE SODIUM Tab 50 mg......................................Laxofast 50 Tab 120 mg....................................Laxofast 120

97.83 27.27 3.95 5.49

100 60 100 100 1% 1% 1% Jun-10 Jun-10 Jun-10 (B) Coloxyl Coloxyl

DOCUSATE SODIUM WITH SENNOSIDES ( price and addition of HSS) Tab 50 mg with total sennosides 8 mg .......................Laxsol 6.38 200 HYDROCORTISONE Crm 1% ..........................................Pharmacy Health 3.75 100 g

Jun-10

Coloxyl with Senna

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes Part II - effective 1 April 2010 (continued)

HYDROCORTISONE WITH NATAMYCIN AND NEOMYCIN (Amended chemical name) Crm 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort 2.79 15 g Oint 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort 2.79 15 g OMEPRAZOLE Cap 10 mg .....................................Dr Reddy’s 2.00 28 1% May-09 Losec Omeprazole Omezol Cap 20 mg .....................................Dr Reddy’s 2.85 28 1% May-09 Losec Omeprazole Omezol Cap 40 mg .....................................Dr Reddy’s 3.35 28 1% May-09 Losec Omeprazole Omezol Note – Dr Reddy’s Omeprazole cap 10 mg, 20 mg and 40 mg, 28 cap packs, to be delisted 1 June 2010. Please note that the 30 capsule packs remain listed. PIPERACILLIN SODIUM WITH TAZOBACTAM SODIUM Inj 4 g with tazobactam sodium 500 mg .........................Tazocin EF TOPIRAMATE Tab 25 mg......................................Arrow -Topiramate Tab 50 mg......................................Arrow -Topiramate Tab 100 mg....................................Arrow -Topiramate Tab 200 mg....................................Arrow -Topiramate TRANEXAMIC ACID ( price and addition of HSS) Tab 500 mg....................................Cyclokapron ZIDOVUDINE (AZT) Cap 100 mg ...................................Retrovir Oral liq 10 mg per ml ......................Retrovir

12.00

Jun-10

DBL Zobacin

11.07 18.81 31.99 55.19

60 60 60 60

32.92 145.00 29.00

100 100 200 ml

1% 1% 1%

Jun-10 Jun-10 Jun-10

(B) (B) (B)

Section H changes to Part IV

Effective 1 April 2010

CLOPIDOGREL Tab 75 mg Plavix Up to 4 weeks supply post stenting. Not to be funded for acute coronary syndrome or transient ischaemic attacks.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands Symbols 3TC ................................................................... 22 A Alpha-Keri Lotion ............................................... 24 Ambrisentan ...................................................... 28 Amoxycillin ........................................................ 24 Apo-Diclo SR ..................................................... 26 Apo-Moclobemide.............................................. 28 Aquasun Sensitive SPF 30+ .............................. 24 Arrow-Bendrofluazide ................................... 18, 27 Arrow-Lamotrigine ............................................. 24 Arrow-Metformin................................................ 24 Arrow-Testosterone ..................................... 18, 28 Arrow-Topiramate .............................................. 29 Aspen Ciprofloxacin ........................................... 28 Azol ................................................................... 28 B Bendrofluazide ............................................. 18, 27 Bisacodyl ........................................................... 28 C Calcitriol ............................................................ 24 Calcitriol-AFT ..................................................... 24 Calci-Tab 500 .................................................... 19 Calci-Tab 600 .................................................... 19 Calcium carbonate ............................................. 19 Calsource .......................................................... 19 Capadex............................................................. 25 Chloramphenicol ................................................ 28 Chlorhexidine gluconate ............................... 22, 25 Chlorsig ............................................................. 28 Ciprofloxacin ...................................................... 28 Cisplatin....................................................... 22, 27 Cisplatin Ebewe............................................ 22, 27 Clindamycin ....................................................... 27 Clomipramine hydrochloride ......................... 26, 27 Clopidogrel ........................................................ 29 Clopress ...................................................... 26, 27 Crotamiton ................................................... 22, 25 Cyclokapron....................................................... 29 D D-Zol ........................................................... 26, 27 Dalacin C ........................................................... 27 Danazol.................................................. 26, 27, 28 Depo-Provera ..................................................... 27 Dextrochlorpheniramine maleate ......................... 24 Dextropropoxyphene with paracetamol ............... 25 DHC Continus .................................................... 28 Diclax SR ........................................................... 25 Diclofenac sodium ....................................... 25, 26 Dihydrocodeine tartrate ...................................... 28 Diurin 500 .................................................... 25, 27 Docusate sodium ................................... 19, 27, 28 Docusate sodium with sennosides ..................... 28 Dr Reddy’s Omeprazole...................................... 29 Dulcolax............................................................. 28 Duphaston ......................................................... 26 Dydrogesterone.................................................. 26 E Ethinyloestradiol with levonorgestrel ................... 25 Eurax ........................................................... 22, 25 F Ferodan ............................................................. 19 Ferro-F-Tabs ...................................................... 19 Ferro-Gradumet.................................................. 19 Ferro-tab ............................................................ 19 Ferrograd-Folic................................................... 19 Ferrous fumarate ................................................ 19 Ferrous fumarate with folic acid .......................... 19 Ferrous gluconate with ascorbic acid .................. 19 Ferrous sulphate ................................................ 19 Ferrous sulphate with folic acid .......................... 19 Fluorouracil Ebewe ................................. 18, 26, 27 Fluorouracil sodium................................ 18, 26, 27 Furosemide .................................................. 25, 27 G Gemcitabine Ebewe............................................ 19 Gemcitabine hydrochloride ................................. 19 Gemzar .............................................................. 19 GenRx Moclobemide .......................................... 26 H Healtheries Iron with Vitamin C ........................... 19 Hydrocortisone ............................................ 25, 28 Hydrocortisone with natamycin and neomycin .... 29 I Imigran .............................................................. 24 L Lamivudine ........................................................ 22 Lamotrigine........................................................ 24 Laxofast 50 ............................................ 19, 27, 28 Laxofast 120 .......................................... 19, 27, 28 Laxsol ................................................................ 28 Lemnis Fatty Cream HC...................................... 25 Lignocaine ................................................... 18, 27 Lyderm .............................................................. 24 M Magnesium sulphate .......................................... 19 MDS Quick Card .......................................... 22, 25 Medroxyprogesterone acetate....................... 27, 28 Megace........................................................ 22, 25 Megestrol acetate......................................... 22, 25 Metformin hydrochloride .................................... 24 Moclobemide ............................................... 26, 28 N Navelbine ........................................................... 20

Index

Pharmaceuticals and brands O Omeprazole........................................................ 29 P Paradex ............................................................. 25 Permethrin ......................................................... 24 Pharmacy Health ................................................ 28 Pimafucort ......................................................... 29 Piperacillin sodium with tazobactam sodium ....... 29 Plavix ................................................................. 29 Polaramine......................................................... 24 Pregnancy tests - hCG urine ......................... 22, 25 Provera .............................................................. 27 R Ranbaxy Amoxicillin ........................................... 24 Retrovir .............................................................. 29 S Sodium fluoride .................................................. 19 Sumagran .......................................................... 24 Sumatriptan ....................................................... 24 Sunscreens, proprietary ..................................... 24 T Tazocin EF ......................................................... 29 Teniposide ......................................................... 24 Tenoxicam ......................................................... 28 Testosterone undecanoate............................ 18, 28 Topiramate......................................................... 29 Tranexamic acid ................................................. 29 Trifeme .............................................................. 25 V Vinorelbine ......................................................... 20 Vinorelbine Ebewe .............................................. 20 Volibris .............................................................. 28 Vumon ............................................................... 24 W Wool fat with mineral oil ..................................... 24 Z Zidovudine (AZT) ................................................ 29 Zincaps .............................................................. 19 Zinc sulphate...................................................... 19

Index

Pharmaceuticals and brands

Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-9376 (Print) ISSN 1179-3686 (Online)

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

Metadata

Title

Schedule Update - effective 1 May 2010

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May 2010 Section H for April and May 2010 Contents Summary of PHARMAC decisions effective 1 May 2010 ….. 3 Gemcitabine hydrochloride and vinorelbine – access widening … 5 Lignocaine…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.